Diclectin Therapy for Nausea and Vomiting of Pregnancy: Effects of Optimal Dosing
Authors:
- Adrienne EinarsonAEAdrienne Einarson
- Caroline MaltepeCMCaroline Maltepe
- Jacob WolpinJWJacob Wolpin
- Gideon KorenGKGideon Koren
- 1 October 2003
- journal article
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 25 (10) , 830-833
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
- Canadian Society of Pharmacology and Therapeutics
This publication has 6 references indexed in Scilit:
- Motherisk—PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancyAmerican Journal of Obstetrics and Gynecology, 2002
- The teratogenicity of drugs for nausea and vomiting of pregnancy: Perceived versus true riskAmerican Journal of Obstetrics and Gynecology, 2002
- The Safety of Higher Than Standard Dose of Doxylamine‐Pyridoxine (Diclectin®) for Nausea and Vomiting of PregnancyThe Journal of Clinical Pharmacology, 2001
- Severity of Nausea and Vomiting During Pregnancy: What Does It Predict?Birth, 1999
- Bendectin and birth defects: I. A meta‐analysis of the epidemiologic studiesTeratology, 1994
- Development of reliable and valid measures of nausea and vomitingCancer Nursing, 1984